NDC 68462-325 – Indomethacin

Indomethacin 75 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug 2 recalls

Product NDC68462-325

Product details

Brand name
Indomethacin
Generic name
Indomethacin
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA203501
Marketed since
June 22, 2017
Listing expires
December 31, 2026
Pharmacologic class
Nonsteroidal Anti-inflammatory Drug

Active ingredients

Uses, dosage, side effects and warnings for Indomethacin →

Package NDC codes (5)

Package NDCDescriptionSince
68462-325-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-01)Jun 22, 2017
68462-325-05500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-05)Jun 22, 2017
68462-325-101000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-10)Jun 22, 2017
68462-325-6060 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-60)Jun 22, 2017
68462-325-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-90)Jun 22, 2017

Recalls mentioning this NDC

Other Indomethacin products